SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-035908
Filing Date
2024-03-25
Accepted
2024-03-25 16:03:20
Documents
12
Period of Report
2024-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stok-20240325.htm   iXBRL 8-K 39530
2 EX-99.1 stok-ex99_1.htm EX-99.1 186864
  Complete submission text file 0000950170-24-035908.txt   350240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stok-20240325.xsd EX-101.SCH 24893
15 EXTRACTED XBRL INSTANCE DOCUMENT stok-20240325_htm.xml XML 4701
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 24779171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)